Disproportionate mitral regurgitation: another myth? A critical appraisal of echocardiographic assessment of functional mitral regurgitation.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 01 06 2020
accepted: 17 08 2020
pubmed: 28 8 2020
medline: 13 4 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

The contradictory findings of recent prospective randomized controlled trials assessing the impact of percutaneous edge-to-edge repair in patients with functional or secondary mitral regurgitation have triggered a lively discussion about an "integrated" echocardiographic approach for grading severity of mitral regurgitation. In the MITRA-FR trial, the COAPT trial and the REDUCE-FMR trial echocardiographic assessment of the severity of mitral regurgitation was consistent with principles set forth by the current echocardiographic guidelines and analysed in its best settings by expert international leaders in the field of echocardiography. However, serious inconsistencies appeared in the presented echocardiographic assessments regarding cardiac output and regurgitant fraction. A new term "disproportionate functional mitral regurgitation" was introduced describing a situation where the increase of effective regurgitant orifice area exceeds the enlargement of the left ventricular end-diastolic volumes. Further discussion resulted in the idea of a "new conceptional framework" for distinguishing "proportionate" and "disproportionate" functional mitral regurgitation. The aim of this viewpoint is to dispute conclusions based on the term "disproportionate" mitral regurgitation. A "disproportionate" FMR is highly questionable because disproportionateness of flow in communication vessels cannot exist. In addition, a proposal of echocardiographic assessment based on a conventional comprehensive transthoracic echocardiography is given to avoid obvious hemodynamic contradictions.

Identifiants

pubmed: 32851501
doi: 10.1007/s10554-020-01975-6
pii: 10.1007/s10554-020-01975-6
pmc: PMC7878255
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-196

Références

Eur Heart J. 1994 Oct;15(10):1335-9
pubmed: 7821308
N Engl J Med. 2019 May 16;380(20):1979-1980
pubmed: 31091393
N Engl J Med. 2018 Dec 13;379(24):2297-2306
pubmed: 30145927
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
JAMA Cardiol. 2020 Apr 1;5(4):476-481
pubmed: 32074247
Eur J Heart Fail. 2019 Jul;21(7):852-861
pubmed: 31116485
Circulation. 1997 Feb 4;95(3):636-42
pubmed: 9024151
N Engl J Med. 2019 May 16;380(20):1979
pubmed: 31091392
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Clin Res Cardiol. 2020 Mar;109(3):271-288
pubmed: 31482241
ESC Heart Fail. 2019 Aug;6(4):678-685
pubmed: 31347297
J Am Coll Cardiol. 2018 Feb 6;71(5):547-563
pubmed: 29406861
J Am Soc Echocardiogr. 1991 Jan-Feb;4(1):57-66
pubmed: 2003938
Circulation. 1991 Oct;84(4):1481-9
pubmed: 1914090
J Am Coll Cardiol. 2015 Mar 24;65(11):1078-88
pubmed: 25790878
N Engl J Med. 2018 Dec 13;379(24):2307-2318
pubmed: 30280640
Ann Thorac Surg. 2006 Mar;81(3):1153-61
pubmed: 16488757
JAMA Cardiol. 2020 Apr 1;5(4):469-475
pubmed: 32074243
Am J Cardiol. 1999 Feb 15;83(4):535-41
pubmed: 10073857
JACC Heart Fail. 2019 Nov;7(11):945-955
pubmed: 31521683
Clin Res Cardiol. 2019 Sep;108(9):974-989
pubmed: 30929035
Int J Cardiol Heart Vasc. 2018 Nov 19;22:18-19
pubmed: 30505928
J Am Coll Cardiol. 2019 Dec 17;74(24):2969-2979
pubmed: 31574303
Circulation. 2019 Aug 27;140(9):779-789
pubmed: 31070944
JACC Cardiovasc Imaging. 2019 Feb;12(2):353-362
pubmed: 30553663
N Engl J Med. 2019 May 16;380(20):1978-1979
pubmed: 31091391
JAMA Cardiol. 2020 Apr 1;5(4):377-379
pubmed: 32074245
J Am Coll Cardiol. 2012 Oct 16;60(16):1470-83
pubmed: 23058312
J Am Coll Cardiol. 1998 Aug;32(2):427-31
pubmed: 9708471
J Am Coll Cardiol. 2019 May 28;73(20):2506-2517
pubmed: 31118144
J Am Coll Cardiol. 2014 Dec 30;64(25):2792-801
pubmed: 25541133
Eur Heart J Cardiovasc Imaging. 2019 Jun 1;20(6):620-624
pubmed: 31115470
Eur Heart J Cardiovasc Imaging. 2017 Mar 1;18(3):254-275
pubmed: 28363204
N Engl J Med. 2019 May 16;380(20):1978
pubmed: 31091390
ESC Heart Fail. 2020 Aug;7(4):1645-1652
pubmed: 32358886
Eur Heart J. 2019 Jul 14;40(27):2189-2193
pubmed: 31005977
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611-44
pubmed: 23733442

Auteurs

Andreas Hagendorff (A)

Department of Cardiology, University of Leipzig, Leipzig, Germany. Andreas.Hagendorff@medizin.uni-leipzig.de.
Department of Cardiology, University Hospital Leipzig, Liebigstrasse 20, 04103, Leipzig, Germany. Andreas.Hagendorff@medizin.uni-leipzig.de.

Fabian Knebel (F)

Department of Cardiology, University of Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Speaker of the Working Group "Cardiovascular Ultrasound" of the German Society of Cardiology, Düsseldorf, Germany.

Andreas Helfen (A)

Department of Cardiology, St. Marien Hospital Lünen, Lünen, Germany.
Co-Speaker of the Working Group "Cardiovascular Ultrasound" of the German Society of Cardiology, Düsseldorf, Germany.

Stephan Stöbe (S)

Department of Cardiology, University of Leipzig, Leipzig, Germany.

Torsten Doenst (T)

Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich Schiller University of Jena, Jena, Germany.

Volkmar Falk (V)

Department of Cardiothoracic and Vascular Surgery, University of Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
Department of Health Science and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland.
German Center of Cardiovascular Research, Partner Site Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH